ADC Therapeutics SA (NYSE:ADCT)
| 17.20 Delayed Data As of Jan 14 |  -1.79 / -9.43%Today’s Change | 16.35 Today|||52-Week Range 34.48 | -14.85% Year-to-Date |
Latest ADCT News | Press Releases
No recent news for ADC Therapeutics SA.
Today’s Trading
| Previous close | 18.99 |
| Today’s open | 19.08 |
| Day’s range | 16.40 - 19.83 |
| Volume | 346,371 |
| Average volume (3 months) | 163,338 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | -116.16% |
| Earnings growth (this year) | -27.30% |
| Earnings growth (next 5 years) | +5.94% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.94 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 17, 2022 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$246.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
